DR. MEGAN COLLYER M.D. NPI 1215097464

NPI Details

DR. Megan Collyer, M.D. is a family medicine in Bourne, MA with 29 years of experience. The provider is family Medicine is the medical specialty which is concerned with the total health care of the individual and the family. It is the specialty in breadth which integrates the biological, clinical, and behavioral sciences. The scope of family medicine is not limited by age, sex, organ system, or disease entity. DR. Megan Collyer, M.D. NPI is 1215097464. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL
Graduation Year:1996

The provider's business location address is:

2 TECHNOLOGY PARK DR
SUITE A
BOURNE, MA
ZIP 02532-341
Phone: (508) 743-9543

The NPI 1215097464 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Hemoglobin a1c level (HCPCS:83036)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
• Urine microalbumin (protein) level (HCPCS:82043)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Blood creatinine level (HCPCS:82565)
• Vitamin d-3 level (HCPCS:82306)
• Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Magnesium level (HCPCS:83735)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Bacterial colony count, urine (HCPCS:87086)
• Blood potassium level (HCPCS:84132)
• Blood sodium level (HCPCS:84295)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Administration of pneumococcal vaccine (HCPCS:G0009)
• Automated urinalysis test (HCPCS:81003)
• Fee covid-19 vac 13 res (HCPCS:0124A)
• Bacterial culture for aerobic isolates (HCPCS:87077)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Phosphate level (HCPCS:84100)
• Liver enzyme (sgpt), level (HCPCS:84460)
• Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution (HCPCS:87186)
• Parathormone (parathyroid hormone) level (HCPCS:83970)
• Calcium level, total (HCPCS:82310)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use (HCPCS:90677)
• Iron level (HCPCS:83540)
• Blood glucose (sugar) level (HCPCS:82947)
• Adm sarscov2 30mcg/0.3ml bst (HCPCS:0004A)
• Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit (HCPCS:G0438)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Adm sarscv2 30mcg trs-sucr b (HCPCS:0054A)
• Urinalysis, manual test (HCPCS:81002)
• Uric acid level, blood (HCPCS:84550)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza (HCPCS:87428)
• Albumin (protein) level (HCPCS:82040)
• Testing for presence of drug, read by direct observation (HCPCS:80305)
• Pneumococcal vaccine, 23-valent (HCPCS:90732)
• Analysis for antibody borrelia burgdorferi (lyme disease bacteria) (HCPCS:86618)
• Liver function blood test panel (HCPCS:80076)
• Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment (HCPCS:G0402)

The enumeration date for this NPI number is 12/11/2006 and was last updated on 3/11/2008.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.